Stock Ratings / Health Care / CUPR / options

CLGN (50) LFWD (46) HSCS (43) RGNT (44) ⌘ Pro Terminal →

Cuprina Holdings (Cayman) Limited (Class A) (CUPR) Options Positioning, Max Pain & Unusual Sweeps

$1.84 -1.07% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.83

Cuprina Holdings (Cayman) Limited (Class A) (CUPR) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $14.1M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.83 (-0.38%)🧬 Dilution Drag (+1.28% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-12% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CUPR)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (32/100 Composite)

🔍 WHY CUPR SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (47% of score)

FRED Regime × Technicals: 3% of 52W Range • RSI-14 at 40.3 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Whale & Options Positioning+9/20 pts (28% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+1.28% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$1.69+12.4% Next Q

Q2 (-2Q)

Grade E$1.90-2.6% Next Q

Q3 (-1Q)

Grade E$1.85-0.5% Next Q

Current

Grade E$1.84-9.2% Hist 90D α

Trajectory: E (24) → E (32)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CUPR Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CUPR currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.30) and Max Pain ($1.93) forces dealer call-delta covering toward $15.54.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.28% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CUPR• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CUPR Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 32%NO 68%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±12.5%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (CUPR)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for CUPR.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CUPR)

✓Walkthrough of CUPR's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CUPR // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -8.91%▲ RESISTANCE BREAKOUT

2026-10-30O $1.87H $1.87L $1.71C $1.84VOL 11.8K

RES: $1.23SUP: $0.43SMA50: $2.30SMA200: $3.02

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CUPR Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CUPR Butterfly Map → + Track CUPR →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +9.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CUPR today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CUPR. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CUPR today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CUPR)

Health Care Rank #900 of 1016 ⚔️ CLGN vs CUPR Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CUPR vs. CLGN, LFWD, HSCS, RGNT)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Cuprina Holdings (Cayman) Limited (Class A) (CUPR) ranks #900 by composite RQD confidence (32/100, grade E) and #862 by equity capitalization ($14.1M). Within this direct 5-issuer industry benchmark cohort, CUPR leads on earnings valuation at N/A trailing P/E, while CUPR leads on capital efficiency and profitability with -35.0% ROIC and -1.3% gross margin. CLGN currently holds the highest overall quantitative score in the immediate peer group at 50/100 (D) compared with CUPR at 32/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CUPR ACTIVE Cuprina Holdings (Cayman) Limited (Class A)	E	32/100	—	-1.3%	-35.0%	-1.07%	$14.1M	Benchmark Subject
CLGN CollPlant Biotechnologies Ltd	D	50/100	—	64.8%	-35.0%	+11.39%	$12.7M	/clgn-vs-cupr →
LFWD Lifeward Ltd.	D	46/100	—	96.0%	-35.0%	+2.78%	$16.7M	/lfwd-vs-cupr →
HSCS HeartSciences Inc.	D-	43/100	—	59.1%	-35.0%	+7.12%	$17.5M	/hscs-vs-cupr →
RGNT Regentis Biomaterials Ltd.	D	44/100	—	—	-35.0%	+10.57%	$9.6M	/rgnt-vs-cupr →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2024–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001995704

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cuprina Holdings (Cayman) Limited (Class A) (CUPR) reported GAAP revenue of $38.8K (+9.2% vs. FY2024 revenue of $35.5K ) , GAAP net income of -$3.6M, operating cash flow of -$7.1M, and free cash flow of -$7.1M (-672.8% YoY). On the balance sheet, CUPR closed FY2025 with $6.6M in total assets against $98.1K in total debt (Altman Z-Score: 0.36, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$38.8K	-$3.6M	-$7.1M	-$7.1M	$6.6M	$98.1K
FY2024 (FY)	2024-12-31	$35.5K	-$1.1M	-$908.6K	-$924.7K	$1.3M	$120.4K

3. CUPR Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CUPR stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Cuprina Holdings (Cayman) Limited (Class A) (NASDAQ: CUPR) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $1.84 (-1.07% 1D, market cap $14.1M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 9/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, CUPR ranks #900 in composite RQD confidence.

How does CUPR compare to CLGN and LFWD in the Health Care sector?

Within the Health Care sector (Industrial Specialties), CUPR carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of -1.3%, and ROIC of -35.0%. By comparison, CLGN (CollPlant Biotechnologies Ltd) holds a D grade (50/100 RQD, P/E N/A, ROIC -35.0%, cap $12.7M) and LFWD (Lifeward Ltd.) posts a D grade (46/100 RQD, P/E N/A, ROIC -35.0%, cap $16.7M). Among the 5-stock peer group, CUPR leads on earnings multiple (N/A) while CUPR leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CUPR?

Per CUPR's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001995704), Cuprina Holdings (Cayman) Limited (Class A) generated $38.8K in revenue (+9.2% YoY), -$3.6M in net income, and -$7.1M in free cash flow against $6.6M in total assets and $98.1K in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CUPR trading relative to its 50-day, 200-day, and 52-week technical levels?

CUPR last traded at $1.84 (-1.07% on volume of 25,732 shares), positioning the stock -20.00% below its 50-day simple moving average ($2.30) and -39.07% below its 200-day simple moving average ($3.02). Across its 52-week range of $1.45 to $14.80, CUPR sits at the 2.9% percentile with a 14-day RSI of 40.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.61 to $2.07).

CUPR Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is CUPR's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for CUPR.

Direct Sub-Reports: CUPR RQD Cockpit CUPR 12M Forecast CUPR Earnings & Move CUPR Dividends & DRIP CUPR Insiders & 13F CUPR Whale Options CUPR Profit Sankey CUPR News & Why